
Opinion|Videos|May 29, 2024
Identifying the Most Impactful Disease Areas and Patient Populations for PDTs
Diana Brixner, PhD, highlights the potential for prescription digital therapeutics (PDTs) to have impact in areas such as facilitating behavioral change for mental health conditions and strengthening adherence for complex disease states with intricate drug regimens.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on AJMC
1
GLP-1 Therapies in 2026: Beyond Blood Sugar and the Scale
2
ACA Enrollment Erosion Deepens After Open Enrollment Ends
3
What ADA 2026 Data Reveal About the Growing Gap in Ketone Monitoring: Eden Miller, DO
4
Efgartigimod Effective in Broad Subsets of Patients With gMG
5


